Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.

MLA

Kuemmel, Sherko, et al. “Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.” JAMA Surgery, vol. 158, no. 8, Aug. 2023, pp. 807–15. EBSCOhost, https://doi.org/10.1001/jamasurg.2023.1772.

APA

Kuemmel, S., Heil, J., Bruzas, S., Breit, E., Schindowski, D., Harrach, H., Chiari, O., Hellerhoff, K., Bensmann, E., Hanf, V., Graßhoff, S.-T., Deuschle, P., Belke, K., Polata, S., Paepke, S., Warm, M., Meiler, J., Schindlbeck, C., Ruhwedel, W., … Reinisch, M. (2023). Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer. JAMA Surgery, 158(8), 807–815. https://doi.org/10.1001/jamasurg.2023.1772

Chicago

Kuemmel, Sherko, Joerg Heil, Simona Bruzas, Elisabeth Breit, Dorothea Schindowski, Hakima Harrach, Ouafaa Chiari, et al. 2023. “Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.” JAMA Surgery 158 (8): 807–15. doi:10.1001/jamasurg.2023.1772.